[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857-412-7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 661153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Forte CPA", "age": 45, "title": "President, CFO, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 631996, "exercisedValue": 0, "unexercisedValue": 1765836}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Alves", "age": 45, "title": "Senior VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. O'Connell M.D.", "age": 70, "title": "Executive Vice President of Clinical Development and Medical Affairs", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.38, "dayLow": 1.38, "dayHigh": 1.45, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.38, "regularMarketDayLow": 1.38, "regularMarketDayHigh": 1.45, "payoutRatio": 0.0, "beta": 0.835, "forwardPE": -0.486532, "volume": 143708, "regularMarketVolume": 143708, "averageVolume": 262103, "averageVolume10days": 70640, "averageDailyVolume10Day": 70640, "bid": 1.37, "ask": 1.5, "bidSize": 1, "askSize": 1, "marketCap": 61978076, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 4.29, "priceToSalesTrailing12Months": 57.761486, "fiftyDayAverage": 1.37834, "twoHundredDayAverage": 1.95293, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -63236948, "profitMargins": 0.0, "floatShares": 22647519, "sharesOutstanding": 42891400, "sharesShort": 593485, "sharesShortPriorMonth": 555076, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0138, "heldPercentInsiders": 0.0125, "heldPercentInstitutions": 0.69456, "shortRatio": 4.41, "shortPercentOfFloat": 0.020399999, "impliedSharesOutstanding": 43508500, "bookValue": 2.917, "priceToBook": 0.49537197, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -127894000, "trailingEps": -3.02, "forwardEps": -2.97, "enterpriseToRevenue": -58.935, "enterpriseToEbitda": 0.493, "52WeekChange": -0.57098764, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 1.445, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 124228000, "totalCashPerShare": 2.896, "ebitda": -128276000, "totalDebt": 1372000, "quickRatio": 7.175, "currentRatio": 7.415, "totalRevenue": 1073000, "debtToEquity": 1.097, "revenuePerShare": 0.025, "returnOnAssets": -0.40187, "returnOnEquity": -0.71639, "grossProfits": 395000, "freeCashflow": -67796248, "operatingCashflow": -117510000, "grossMargins": 0.36813, "ebitdaMargins": 0.0, "operatingMargins": -121.97763, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1751395663, "cryptoTradeable": false, "fiftyTwoWeekChangePercent": -57.098763, "earningsTimestamp": 1747166700, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754510400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.02, "epsForward": -2.97, "epsCurrentYear": -2.11, "priceEpsCurrentYear": -0.6848342, "fiftyDayAverageChange": 0.06666005, "fiftyDayAverageChangePercent": 0.048362557, "twoHundredDayAverageChange": -0.5079299, "twoHundredDayAverageChangePercent": -0.2600861, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "averageAnalystRating": "2.3 - Buy", "marketState": "REGULAR", "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.9568393, "regularMarketPrice": 1.445, "shortName": "Repare Therapeutics Inc.", "longName": "Repare Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "regularMarketChange": 0.055000067, "regularMarketDayRange": "1.38 - 1.45", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 262103, "fiftyTwoWeekLowChange": 0.55500007, "fiftyTwoWeekLowChangePercent": 0.6235956, "fiftyTwoWeekRange": "0.89 - 4.29", "fiftyTwoWeekHighChange": -2.8449998, "fiftyTwoWeekHighChangePercent": -0.6631701, "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]